Financial report interval: 2025.12.31 - 2026.03.31
Overview: Qianhong Bio-pharma(002550) the Revenue is 358.08 M (-20.58%);the EBIT is 106.72 M (-41.24%);the EPS is 0.0678 (-47.36%).